LOKON PHARMA AB
The strategy of Lokon is to modulate the tumor microenvironment and simultaneously activate the immune system to attack the tumor using immunostimulatory gene therapy.
LOKON PHARMA AB
Industry:
Biotechnology Therapeutics
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.lokonpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Font Awesome Apache Google Maps CloudFront CPanel SSL PhotoSwipe
Current Employees Featured
Official Site Inspections
http://www.lokonpharma.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Lokon Pharma AB"
Lokon Pharma | Home
Lokon Pharma is a Swedish biotech company in the forefront of developing tumor microenvironment (TME) gene engineering vectors for cancer.See details»
About us - Lokon Pharma
Lokon Pharma is a Swedish biotech company in the forefront of developing tumor microenvironment (TME) gene engineering vectors for cancer.See details»
Lokon Pharma AB | LinkedIn
Next generation cancer immunotherapeutics | LOKON PHARMA is a Swedish biotech company in the forefront of developing immunostimulatory gene therapy for cancer-based on oncolytic …See details»
Lokon Pharma AB - Crunchbase Company Profile
Where is Lokon Pharma AB's headquarters? Lokon Pharma AB is located in Uppsala, Uppsala Lan, Sweden. Who are Lokon Pharma AB's competitors? Alternatives and possible competitors to Lokon Pharma AB may include …See details»
Pipeline - Lokon Pharma
Lokon Pharma focuses on the development of LOAd therapy for different types of cancer and in combination with other cancer therapeutics including chemotherapy and checkpoint blockade antibody therapy.See details»
Lokon Pharma - BIO International Convention | BIO
Jun 7, 2023 · Lokon Pharma is a privately owned, Swedish biotech company developing immunostimulatory gene therapy for cancer with a focus on pancreatic cancer. The therapeutic platform stems from Uppsala University in Sweden.See details»
Lokon Company Profile 2024: Valuation, Funding
Developer of immunostimulatory gene therapies intended to treat cancer. The company develops therapies that are meant to address cancer-related treatments, enabling people to modulate the tumor microenvironment and …See details»
SPEED OF LIFE – Lokon Pharma AB - STUNS Life science
Lokon Pharma is a biotech company in Sweden based on research from well renowned Uppsala University. They develop a new cancer medicine based on a virus that selectively kill tumor cells and activates the patients own immune …See details»
Lokon Pharma and Affibody Initiates a Collaboration to …
Jan 12, 2022 · Lokon Pharma AB, a leading biotech company in the area of immunostimulatory gene therapy for cancer delivered by uniquely engineered oncolytic viruses, today announced a collaboration with Affibody AB …See details»
Lokon Pharma and Affibody Initiates a Collaboration to Develop
Lokon Pharma AB, a leading biotech company in the area of immunostimulatory gene therapy for cancer delivered by uniquely engineered oncolytic viruses, today announced a collaboration …See details»
Lokon Pharma - Craft
Lokon Pharma is a pharmaceutical company developing cancer immunotherapies for cancer therapeutics. Its LOAd technology is a family of armed oncolytic viruses that can activate an …See details»
For patients - Lokon Pharma
Lokon Pharma AB is committed bringing innovative medicinal products that are safe and proven effective to patients. At the present time, we are focused on conducting clinical trials needed to …See details»
Manufacturing the next generation of cancer immunotherapeutics
Lokon Pharma’s immunostimulatory gene therapy, delivered in oncolytic adenoviruses, are poised to enter pivotal trials for cancer. Biovian Oy is manufacturing Lokon’s immunotherapeutics for...See details»
Our Solution - Lokon Pharma
Our solution primes the immune system to detect and disarm the tumor, while mounting a tumor-specific immune response. The immune system can recognize and kill microbes but also …See details»
Affibody and Lokon Pharma initiate collaboration - NLS
Jan 12, 2022 · Lokon Pharma has announced a collaboration with Affibody to combine oncolytic viruses with Affibody molecules. “Lokon’s oncolytic adenovirus platform encodes human …See details»
Lokon Pharma and Affibody Initiates a Collaboration to Develop …
Jan 12, 2022 · Lokon Pharma AB, a leading biotech company in the area of immunostimulatory gene therapy for cancer delivered by uniquely engineered oncolytic viruses, today announced …See details»
Lokon Pharma AB signs an agreement with Biovian - Biovian
Jun 15, 2021 · Lokon Pharma AB, a company developing next-generation cancer therapeutics, has selected Biovian Oy as a CDMO partner for GMP manufacturing of LOAd703 for a pivotal …See details»
Career - Lokon Pharma
Do you have extensive professional experience within immunotherapy, oncology, gene therapy, quality control, pharmacovigilance, data management, project management, and/or good …See details»
Börsnotering av Lokon Pharma AB på Nasdaq Stockholm
Ordförande pratar löst om ett spann frÃ¥n fyra till mÃ¥nga miljarder kronor. I mitten av oktober 2021 skrev Dagens Industri att Nexttobe (Bengt Ã…gerup) planerar att notera Lokon Pharma pÃ¥ …See details»
Lokon Pharma | News
Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main focus.See details»